Last edition
News about Global Pharma
Alembic Pharma Acquires American Utility Therapeutics for USD 12 Million
Alembic Pharmaceuticals Inc., a wholly owned subsidiary of Alembic Pharmaceuticals Ltd., has acquired American Utility Therapeutics for USD 12 million (over INR 100 crore), strengthening its presence in the US market.
Global Pharma | 03/07/2025 | By Manvi | 238
Merck recently reported a 17% decline in sales of its HPV vaccine Gardasil in China, citing increasing price pressure from domestic manufacturers and the impact of China’s ongoing anti-corruption drive in the healthcare industry.
Global Pharma | 03/07/2025 | By Darshana | 404
Biocon Biologics Receives European Commission Nod for Denosumab Biosimilars to Improve Bone Health
Biocon Biologics has received European Commission approval for its Denosumab biosimilars, Vevzuo and Evfraxy, thereby expanding access to advanced treatments for bone-related conditions across the EU.
Global Pharma | 03/07/2025 | By Mrinmoy Dey | 235
Lupin Spins Off Consumer Healthcare Arm into New Subsidiary, Appoints New CEO
Lupin noted that the move aligns with their broader strategy to establish a specialised consumer healthcare entity, with an enhanced focus on India’s rapidly growing self-care market.
Global Pharma | 02/07/2025 | By Manvi | 388
Intas Pharma Appoints Udit Sakhuja as Senior General Manager-Global New Product Launch
Prior to joining Intas, Sakhuja served at Dr. Reddy's Laboratories for over four years, where he held key leadership roles including Head of Marketing for Rheumatology and Ortho Biologics & Pain Management Portfolio, as well as Head of Marketing for NBE/NCE Innovative Oncology Assets.
Global Pharma | 02/07/2025 | By Manvi | 314
Regulus Becomes Wholly Qwned Subsidiary of Novartis
Novartis has successfully completed its acquisition of Regulus Therapeutics Inc. (Regulus), which has now become an indirect, wholly owned subsidiary of the Swiss pharmaceutical company.
Global Pharma | 02/07/2025 | By Manvi | 153
Aurobindo's Lyfius Pharma Resumes Penicillin-G Production at Kakinada Plant
Lyfius Pharma, a wholly owned subsidiary of Aurobindo Pharma, has resumed Penicillin-G production after receiving the green light from the Andhra Pradesh Pollution Control Board (APPCB) to operate the Kakinada plant, which had been temporarily paused following a fire in April.
Global Pharma | 01/07/2025 | By Manvi | 1479
Fresenius Kabi Launches FDA Approved Denosumab Biosimilars in US
These denosumab biosimilars are approved by the FDA for all indications of the reference products, Prolia® (denosumab) and Xgeva® (denosumab), respectively.
Global Pharma | 01/07/2025 | By Manvi | 278
Torrent Pharma to Acquire Controlling Stake in JB Pharma from KKR in INR 25,689 Crore Deal
Torrent Pharmaceuticals has announced plans to acquire a controlling stake in JB Pharma from KKR in an INR 25,689 crore deal, paving the way for a merger that will significantly boost its Indian market position and global expansion strategy.
Global Pharma | 01/07/2025 | By Mrinmoy Dey | 460
Biocon Biologics Scales Up Insulin Access in Malaysia
Biocon Biologics has announced that its Malaysian subsidiary has crossed the milestone of supplying over 100 million recombinant human insulin cartridges to Malaysia’s Ministry of Health, reinforcing its commitment to affordable and accessible diabetes care.
Global Pharma | 30/06/2025 | By Mrinmoy Dey | 312
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy